Funds and ETFs Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse 21:00:02 17/05/2024 BST 5-day change 1st Jan Change
231.2 USD -1.63% Intraday chart for Iqvia Holdings Inc. -1.24% -0.09%

ETFs positioned on Iqvia Holdings Inc.

Name Weight AuM 1st Jan change Investor Rating
3.67% 0 M€ 0.00% -
3.45% 0 M€ 0.00% -
2.92% 1 M€ +0.15% -
2.68% 2 M€ -.--%
1.54% 17 M€ +7.73% -
1.33% 1 M€ +2.21% -
1.20% 2 M€ +10.27%
1.04% 8 M€ +5.66%
0.50% 9 M€ -.--% -
0.41% 2 M€ +20.44% -
0.36% 5 M€ -72.95% -
0.24% 1,448 M€ -.--% -
0.24% 219 M€ +17.17% -
0.21% 330 M€ -.--%
0.19% 37 M€ -.--%
0.17% 85 M€ +14.05% -
0.16% 9 M€ +10.44%
0.15% 744 M€ +9.63%
0.15% 8 M€ +7.30% -
0.15% 1 M€ +0.04%
0.14% 276 M€ +11.40% -
0.12% 50 M€ +10.93%
0.12% 6 M€ +17.98% -
0.12% 121 M€ +8.42% -
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
231.2 USD
Average target price
271.4 USD
Spread / Average Target
+17.42%
Consensus
  1. Stock Market
  2. Equities
  3. IQV Stock
  4. Funds and ETFs Iqvia Holdings Inc.